ArticleBMC cancer2025
Tumor index predicts recurrences of patients with pathological stage Ⅰ gastric cancer after radical surgical resection.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundDespite the favorable prognosis of patients with pathological stage I gastric cancer (GC), recurrence may occur in a subset of individuals, and the underlying risk factors are currently being investigated. Tumor index (TI) plays a valuable role in predicting the prognosis of GC. The study aimed to determine the prognostic effect of TI on stage Ⅰ GC.
methodsPatients with stage Ⅰ GC who underwent radical resection were enrolled from the two medical centers from 2010 to 2020. TI was calculated by the pathological T stage multiplied by the maximum tumor diameter. The primary outcome was disease-free survival (DFS) and overall survival (OS). Cox regression analyses were utilized to evaluate the correlation between TI and prognosis.
resultsThe final analysis included a total of 684 patients from two medical centers. Higher TI exhibited a significant correlation with several clinicopathologic features, including N0 stage, TNM stage ⅠB, and positive PNI (all P < 0.05). Patients with high TI showed inferior DFS and OS compared to those with a low TI (P < 0.05). Multivariate analysis revealed that TI was an independent prognostic factor for DFS (hazard ratio (HR) = 2.44, P = 0.010) and OS (HR = 2.39, P = 0.014) in patients with stage Ⅰ GC who underwent radical resection.
conclusionTI was an independent risk factor in recurrence and overall survival for stage Ⅰ GC patients who received curative gastrectomy. Incorporation of TI into clinical decision-making regarding adjuvant therapy and intensity of follow-up may be warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.